Le Lézard
Classified in: Health
Subject: SVY

The conjunctivitis therapeutics market will register a CAGR of over 8% by 2023


NEW YORK, Feb. 11, 2019 /PRNewswire/ -- About this market
Conjunctivitis is inflammation in the inside of the eyelids and the covering of the white of the eye, which causes the conjunctival blood vessels to dilate. While allergic conjunctivitis is known to be prevalent among people with allergies, infectious conjunctivitis is known to spread at a very fast rate. The ease of availability of antibiotic eye drops and ointments for the treatment of bacterial conjunctivitis and antibiotics for viral conjunctivitis is leading to an increase in the use of these therapeutics. The use of therapeutics is primarily to avoid the progression of the disease into severe indications, which could increase the economic burden of patients. Hence, the infectious nature of the disease is expected to increase the adoption rate of therapeutics, thus resulting in the growth of the market during the forecast period. Technavio's analysts have predicted that the conjunctivitis therapeutics market will register a CAGR of over 8% by 2023.

Read the full report: https://www.reportlinker.com/p05734247

Market Overview
Growing allergy cases
Allergic conjunctivitis is caused by various types of allergies such as hay fever and asthma. Being allergic to substances such as dust mites and mold can also increase the risk of infection. Globally. the prevalence of various types of allergies has been growing at a significant rate. The increasing prevalence of allergies such as dust mite allergy and pollen allergy increase the risk of allergic conjunctivitis.
Patent cliff
One of the major challenges faced by the global conjunctivitis therapeutics market is the patent expiration of various drugs in the market. Patent expiration leads to the increasing launch of generic drugs, thereby leading to value erosion of the global market. The patent expiry of blockbuster drugs also impacts the sales of the vendors significantly, making it difficult for vendors to compete in the market. Thus, the patent expiry of blockbuster drugs and the subsequent entry of generics restrict market growth.
For the detailed list of factors that will drive and challenge the growth of the conjunctivitis therapeutics market during the 2019-2023, view our report.

Competitive Landscape
The market appears to be concentrated and with the presence of very few vendors. This market research report will help clients identify new growth opportunities and design unique growth strategies by providing a comprehensive analysis of the market's competitive landscape and offering information on the products offered by companies.

Read the full report: https://www.reportlinker.com/p05734247

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________
Contact Clare: clare@reportlinker.com
US: (339)-368-6001
Intl: +1 339-368-6001

SOURCE Reportlinker


These press releases may also interest you

24 aoû 2019
The Naderi Center in Chevy Chase, Maryland, and Herndon, Virginia, is honored to be the recipient of The Talk Awards 2019. The clinic's dedicated team of board-certified plastic surgeons and talented staff received a perfect 5-star rating in the Talk...

24 aoû 2019
Dahryn Trivedi of Trivedi Global, Inc., and the Trivedi Effect® shared her insights about cell receptors and Vitamin D on FOX 4 in Fort Myers, Florida. She also recently spoke at NASDAQ in New York City about the wealth of health and Vitamin D...

24 aoû 2019
Authors Gopal Nayak and Mahendra Kumar Trivedi were recognized with International No. 1 best-selling status for the scientific research book "Impact of Biofield Treatment on Growth and Anatomical Characteristics of Pogostemon cablin (Benth.) also...

24 aoû 2019
Pomerantz LLP announces that a class action lawsuit has been filed against Curaleaf Holdings, Inc. ("Curaleaf" or the "Company") and certain of its officers.  The class action, filed in United States District Court, for the Eastern District of New...

24 aoû 2019
The Honourable Mary Ng, Minister of Small Business and Export Promotion, will be in Surrey to celebrate innovation and entrepreneurship in the start-up community. She will then announce federal investments in women entrepreneurs. The Minister will be...

24 aoû 2019
Alice Branton, today released research results on the impact of biofield energy treatment on the physicochemical properties of lead. The scientific research shows: Over 1970% increase in particle size Over 177% increase in crystallite size Over 15%...



News published on 11 february 2019 at 20:05 and distributed by: